Novavax (NVAX) concluded the recent trading session at $9.59, signifying a +1.36% move from its prior day's close.

Shares of Novavax Inc. NVAX rose 2.96% to $9.74 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 1.14% to ...

Novavax (NVAX) stock is in focus as Shah Capital again slams the company's leadership despite shareholder backing at the AGM. Read more here.

An update from Novavax ( (NVAX)) is now available. At its June 18, 2026 annual meeting, Novavax stockholders elected Class I directors John C. Jacobs, Gregg H. Alton and Richard J. Rodgers to ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the ...

Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That extends a remarkable 2026 run for the mRNA pioneer. The move pushes ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biomea Fusion (BMEA) and Novavax (NVAX) with bullish sentiments. Deliver institutional-grade market data ...

Shares of Novavax Inc. NVAX shed 4.00% to $9.35 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.12% to 26,121.16 ...

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 11.3% in the afternoon session after documents revealed ...

Is NVAX a good stock to buy? We came across a bullish thesis on Novavax, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on NVAX. Novavax, Inc.’s share was ...